Navigation Links
Dr. Jonathan White Joins Haemonetics as Head of Research and Development
Date:12/8/2008

BRAINTREE, Mass., Dec. 8 /PRNewswire-FirstCall/ --Haemonetics announced today that Dr. Jonathan White will join the Company as head of Research and Development, Vice President of Haemonetics, effective December 8, 2008. In this role, Dr. White will have global responsibility for leading development of the next generation of products to complement Haemonetics' blood management solutions portfolio.

Brad Nutter, Haemonetics' Chairman and CEO, said, "As the global leader in blood management solutions for our customers, we are continually strengthening our product suite with medical devices, information management platforms, and services for blood collectors and hospitals to reduce costs and improve patient outcomes. Dr. White has an extraordinary portfolio of skills and a diverse background which will strengthen our blood management R&D initiatives. We are pleased to welcome him to Haemonetics."

Prior to joining Haemonetics, Dr. White worked for Pfizer Inc. and spent 10 years in a variety of progressive roles encompassing: strategy and business development, leadership of the information technology function, and building R&D platforms for innovation. He led the integration of the R&D organizations of Pfizer and Warner-Lambert Pharmaceutical Company following Pfizer's acquisition of Warner-Lambert. He also served as Chief Innovation Officer for Pfizer. Prior to this, Dr. White worked for McKinsey & Company as a management consultant, where he worked for 6 years in its global healthcare practice serving a variety of clients (including Pfizer) in Europe, China, Africa and the U.S.

Mr. Nutter added, "Dr. White's global business acumen, medical background, strategic thinking, and innovation skills coupled with his knowledge and experience in information technology and consulting services ideally prepare him to play a key role in Haemonetics' leadership team as we build our vision for Blood Management Solutions."

Dr. White, age 49, completed his education and early work as a physician in the United Kingdom. He is a certified neurosurgeon who has worked in both clinical and academic medical settings. He also holds a Masters in Computer Science from Cambridge University as well as a Masters in Business Administration from INSEAD in France.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
2. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
3. Emmy Winner Jonathan Jackson With Rock Band Enation Take On Predators & Rapists
4. Ability to cope with stress can increase good cholesterol in older white men, study finds
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
7. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
8. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
9. Older blacks and Latinos still lag whites in controlling diabetes
10. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
11. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed ... p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed ... pharmaceutical products, garnering increased attention from all stakeholders in the development of new ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a ... closed for the ISE Southeast Awards 2016. Finalists and winners of the ISE® ... Southeast Executive Forum and Awards Gala on March 15, 2016 at the Westin ...
(Date:2/12/2016)... ... ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor Brian Sandoval, ... Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday to dedicate ... be the first Fisher House in Nevada, and will provide free lodging for families ...
(Date:2/12/2016)... ... , ... Erlanger Agency has announced a new partnership in its ongoing community ... on the fight against breast cancer, fundraising for a local woman named Carmen, who ... Carmen is a loving single mother of two boys who also serves as caregiver ...
(Date:2/12/2016)... ... February 12, 2016 , ... For Coast Dental dentist Everet ... RDH, and dental assistant Terrell Moore shortly before 7 a.m. to volunteer at Friday’s ... professionals, donating their time and skills to help hundreds of uninsured and underinsured people ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 ... Companion Diagnostics in Personalized Medicine and Cancer Therapy. ... - High-Growth Diagnostic Testing Markets. - Key Diagnostic ... - Molecular Diagnostics in Genetic Testing. - ... Diagnostics Markets. - Over-the-Counter Diagnostic Products World Markets. ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
(Date:2/11/2016)... 2016  NOIT™ Research LLC, a private, leading-edge autism ... campaign to assist needy families in obtaining one of ... between February 10, 2016 and March 31, 2016, the ... The NOIT is an auditory stimulus that plays a ... skills. Beth Shier , NOIT Research ...
Breaking Medicine Technology: